Literature DB >> 2554818

Cutaneous leishmaniasis. Treatment with itraconazole.

G Albanese1, P Giorgetti, L Santagostino, D Crippa, G Sala.   

Abstract

The chemotherapy of leishmaniasis is still far from satisfactory. Itraconazole, one of the most recent azole antifungal agents, appears to be well tolerated in man. Two patients with cutaneous leishmaniasis (Leishmania tropica), contracted in Saudi Arabia, were treated orally for 2 months with itraconazole (100 mg/d). Both recovered without side effects or abnormalities in their main biologic parameters.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2554818

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


  4 in total

1.  Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patients.

Authors:  G Angarano; P Maggi; S L Coppola; R L Cavaliere
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 3.267

Review 2.  Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections.

Authors:  M Haria; H M Bryson; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

3.  Primary oral Penicillium marneffei infection diagnosed by PCR-based molecular identification and transmission electron microscopic observation from formalin-fixed paraffin-embedded tissues.

Authors:  Xia Hua; Ruifeng Zhang; Hanjun Yang; Song Lei; Yizhi Zhang; Yuping Ran
Journal:  Med Mycol Case Rep       Date:  2012-11-07

4.  Epidemiology, pathology and treatment of cutaneous leishmaniasis in taif region of saudi arabia.

Authors:  Wajihullah Khan; Haytham A Zakai
Journal:  Iran J Parasitol       Date:  2014-09       Impact factor: 1.012
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.